Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 14.61
+0.05 (0.34%)
Apr 28, 2026, 3:00 PM CST
Zhejiang Medicine Market Cap
Zhejiang Medicine has a market cap or net worth of 13.85 billion as of April 28, 2026. Its market cap has increased by 5.74% in one year.
Market Cap
13.85B
Enterprise Value
11.69B
Revenue
8.82B
Ranking
n/a
PE Ratio
18.70
Stock Price
14.61
Market Cap Chart
Since January 2, 2001, Zhejiang Medicine's market cap has increased from 5.53B to 13.85B, an increase of 150.31%. That is a compound annual growth rate of 3.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 13.80B | 5.05% |
| Dec 31, 2025 | 13.14B | -13.86% |
| Dec 31, 2024 | 15.25B | 48.35% |
| Dec 29, 2023 | 10.28B | -8.23% |
| Dec 30, 2022 | 11.20B | -31.56% |
| Dec 31, 2021 | 16.37B | 25.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haoyuan Chemexpress | 15.20B |
| Nanjing King-Friend Biochemical Pharmaceutical | 15.15B |
| Shenzhen Hepalink Pharmaceutical Group | 14.47B |
| Beijing Aosaikang Pharmaceutical | 14.13B |
| Zhejiang Hisun Pharmaceutical | 13.53B |
| Guobang Pharma | 13.39B |
| Shenzhen Chipscreen Biosciences | 13.08B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.02B |